EXIB (Etoricoxib) is a selective cyclooxygenase 2 (COX 2) inhibitor indicated for adults for the symptomatic relief of:
• Osteoarthritis (OA)
• Rheumatoid Arthritis (RA)
• Ankylosing Spondylitis
• Pain and signs of inflammation associated with Acute Gouty Arthritis
• Moderate pain associated with dental surgery
The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of the individual patient’s overall risks.
EXIB is bioequivalent to the innovator and is up to 42% more cost-effective than the leading innovator brand.
DISCLAIMER: The following contents are intended for healthcare professionals only. If you are a patient or general mass viewing this site, we advise you to clarify with your doctor any information you read herein.
|
Generic Name:
|
Etoricoxib
|
|
Brand Name:
|
Exib-90, Exib-120
|
|
Sizes:
|
--
|
|
Preparation:
|
90 mg and 120 mg film-coated tablets
|
|
Name of Manufacturer
|
Hiral Labs Limited
|
|
Place of Manufacturer:
|
India
|
|
Shelf Life
|
36 months
|
|
Storage Condition:
|
Store at temperatures not exceeding 30ºC
|
|
Packaging:
|
Alu/Alu Blister Pack x 10’s (Box of 30s)
|
|
FDA Registration:
|
DRP-10323-02 (Exib-90) / DRP-10322-04 (Exib-120)
|
